PembrolizumabAcquired haemophilia A: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2031卷 / 1期

关键词：

D O I：

10.1007/s40278-024-69607-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：327 / 327

相关论文

共 50 条

[1] PembrolizumabAcquired resistance: case report
Reactions Weekly, 2025, 2042 (1) : 404 - 404
[2] PembrolizumabAcquired resistance: case report
Reactions Weekly, 2021, 1862 (1) : 393 - 393
[3] PembrolizumabAcquired resistance: case report
Reactions Weekly, 2021, 1884 (1) : 354 - 354
[4] PembrolizumabAcquired generalised lipodystrophy: case report
Reactions Weekly, 2022, 1923 (1) : 406 - 406
[5] PembrolizumabAcquired immune-related pneumonitis : case report
Reactions Weekly, 2021, 1864 (1) : 320 - 320
[6] Lorlatinib/paclitaxel/pembrolizumabAcquired resistance and hypothyroidism: case report
Reactions Weekly, 2020, 1800 (1) : 194 - 194
[7] PembrolizumabAcquired idiopathic generalised anhidrosis and lack of efficacy: case report
Reactions Weekly, 2025, 2049 (1) : 307 - 307
[8] Carboplatin/paclitaxel/pembrolizumabAcquired amegakaryocytic thrombocytopenia and lack of efficacy: case report
Reactions Weekly, 2022, 1923 (1) : 127 - 127
[9] IpilimumabFirst report of haemophilia A: case report
Reactions Weekly, 2012, 1387 (1) : 22 - 22
[10] AlemtuzumabFirst report of haemophilia A: case report
Reactions Weekly, 2006, 1108 (1) : 4 - 4

← 1 2 3 4 5 →